Summary of Product Characteristics
last updated on the eMC:
19/10/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 19/10/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.1 - Pharmacodynamic Properties
|
|
Updated on 17/02/2009 and displayed until 19/10/2009
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 7 - Marketing Authorisation Holder
|
|
Updated on 30/04/2007 and displayed until 17/02/2009
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 5.1 - Pharmacodynamic Properties
|
|
Updated on 27/02/2007 and displayed until 30/04/2007
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
|
|
Updated on 06/09/2006 and displayed until 27/02/2007
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
|
|
Updated on 22/08/2006 and displayed until 06/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 10/05/2006 and displayed until 22/08/2006
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
|
|
Updated on 04/08/2004 and displayed until 10/05/2006
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic Indications
|
|
Updated on 29/03/2004 and displayed until 04/08/2004
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
|
|
Updated on 26/09/2003 and displayed until 29/03/2004
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.4 - Special Warnings and Precautions for Use
|
|
Updated on 04/08/2003 and displayed until 26/09/2003
|
Reasons for adding or updating:
|
-
Removal of Black Triangle
|
|
Updated on 19/02/2002 and displayed until 04/08/2003
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 22/01/2002 and displayed until 19/02/2002
|
Reasons for adding or updating:
|
-
Addition of Black Triangle
|
|
Updated on 07/01/2002 and displayed until 22/01/2002
|
Reasons for adding or updating:
|
-
Addition of Black Triangle
|
|
Updated on 18/12/2001 and displayed until 07/01/2002
|
Reasons for adding or updating:
|
-
Addition of Black Triangle
|
|
Updated on 03/12/2001 and displayed until 18/12/2001
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.3 - Preclinical Safety Data
|
|
Updated on 09/07/2001 and displayed until 03/12/2001
|
Reasons for adding or updating:
|
-
Addition of Black Triangle
|
|
Updated on 06/09/1999 and displayed until 09/07/2001
|
Reasons for adding or updating:
|
|
|
|